An Introduction to Human Babesiosis
0.25 CME. This course teaches how to diagnose and treat infections caused by babesia, a malaria-like protozoan parasite that can be transmitted through tick bites, blood transfusions, and organ transplants, or congenitally from mother to fetus. The course also discusses the global distribution of babesia and a new species of babesia, <em>B. odocoilei, </em>which may be causing unrecognized disease.
CourseBy Elizabeth L. Maloney, MD
Antibiotic Treatment of Bartonella Infections
0.5 CME. This course, "Antibiotic Treatment of Bartonella Infections", taught by Dr. Monica Embers, is an educational resource for clinicians to enhance understanding and treatment approaches for Bartonella infections.
CourseBy Monica Embers, PhD
Antibiotic efficacy for treatment of Lyme disease
0.5 CME. This module presents human Lyme disease as a systemic infection with inflammatory pathology. The recommended treatment by two medical associations is covered, with an overview of antibiotic efficacy and a description of antibiotic tolerant-persisters. Findings from nonhuman primate studies are presented, as well as treatment goals and new strategies for eradication of the Lyme disease pathogen.
CourseBy Monica Embers, PhD
Barriers to Lyme disease Treatment: What the data is showing
0.25 CME. In the first study of its kind, two Lyme disease experts gathered data on a question frequently asked by tick-borne disease patients: Why is it so hard to find a Lyme-treating physician, when the need is so great? There are 476,000 new Lyme cases annually, reported from all 50 states, per the CDC. This course answers these questions based on data from a survey of 155 clinicians from 30 states who treat Lyme patients. The study’s goal was to identify the problems that clinicians face when treating these patients, a first step to overcoming these obstacles.
CourseBy Elizabeth L. Maloney, MD
Bartonella species, disease expression and host immunity
1.0 CME. This module provides an overview of the major factors that influence disease expression resulting from Bartonella spp infection with particular attention to bacterial infection strategies and the histopathological progression of lesions observed in both immunocompetent and severely immunodeficient patients.
CourseBy Edward B. Breitschwerdt, DVM
Bartonelloses and comparative infectious disease causation
1.0 CME. This module introduces a new postulate of comparative infectious disease for elusive, slow-growing, zoonotic, vector-borne diseases like Bartonella spp infection and describes the comparative features of Bartonellosis in dogs and people with particular attention to geographic and occupational risk factors.
CourseBy Edward B. Breitschwerdt, DVM
Bartonelloses reservoir hosts: Bats, cats, dogs, mice and men
1.0 CME. This module provides an overview of Bartonella spp. infection, both pathogenic and species-adapted, in various hosts and reservoirs, including bats, cats, dogs, and people.
CourseBy Edward B. Breitschwerdt, DVM
Bartonelloses: History of a hidden pandemic
1.0 CME. This module provides an overview of the history of Bartonella spp infection, from the discovery of Carrion’s disease in South America through trench fever in WWI and the etiology of cat scratch disease in HIV/AIDS epidemic.
CourseBy Edward B. Breitschwerdt, DVM
Bartonelloses: Vectors and other modes of transmission
1.0 CME. This module provides an overview of key vectors and modes of transmission associated with Bartonella spp. infection, with special attention to ongoing debates surrounding tick transmission, perinatal transmission, and other modes, like transfusion and needlesticks.
CourseBy Edward B. Breitschwerdt, DVM
Basic principles of diagnostic testing
0.5 CME. This module reviews the basic laboratory medicine principles of diagnostic testing.
CourseBy Elizabeth L. Maloney, MD
Borrelia miyamotoi Serology in a Clinical Population with Persistent Symptoms and Suspected Tick-Borne Illness
0.5 CME. This course by Dr. Shannon Delaney, a Columbia-trained psychiatrist physician, illuminates key insights from her study "Borrelia miyamotoi Serology in a Clinical Population With Persistent Symptoms and Suspected Tick-Borne Illness.”
CourseBy Shannon Delaney, MD, MA
Borrelia persistence "Bench to Bedside" E-Colloquium
1.0 CME. VectorWise CME's Christine Green, MD brings together Monica Embers, PhD ("bench") and Kenneth Liegner, MD ("bedside") in a discussion about borrelia persistence.
CourseBy Christine Green, MD
Case studies in early Lyme disease
1.0 CME. This presentation provides physicians with clinically relevant information that will enhance their diagnostic and management skills.
CourseBy Elizabeth L. Maloney, MD
Chronic infection and the etiology of dementia
0.5 CME. This CME is presented in loving memory of Susan M. (White) Kelemen, July 4, 1939 – February 26, 2022, by her family, the Montecalvos and the Kelemens.
CourseBy Monica Embers, PhD
Combination Antibiotic Therapy for Treatment of Lyme Disease
0.5 CME. This module discusses differences between antibiotic tolerance and resistance in Lyme disease, demonstrates persistence via tolerance by the Lyme disease spirochete, and evaluates the efficacy of combination therapy versus monotherapy in both animal models and humans.
CourseBy Monica Embers, PhD
Diagnosis of Bartonella species infections
1.0 CME. This module describes the advantages and limitations of different diagnostic methodologies for confirmation of Bartonella spp. infection, as well as recent advances in sample enrichment for direct detection of infection of this immune-evasive, slow-growing bacterial infection.
CourseBy Edward B. Breitschwerdt, DVM
Diagnostic Challenges in Lyme disease
0.5 CME. This module presents the most commonly used tests to diagnose Lyme disease, describes their deficiencies, and provides clinicians with important findings regarding the variability in immune responses among infected individuals. How to interpret the two-tier test, especially the western blot, is discussed in detail and in conjunction with the research findings on immune response differences. Finally, the needs and challenges for new diagnostic modalities are considered.
CourseBy Monica Embers, PhD
Leptospirosis: A Clinical Perspective
0.5 CME. The course addresses Leptospirosis as a global threat that frequently mimics diseases like Lyme disease. It is designed to improve healthcare providers' ability to identify the often non-specific symptoms of Leptospirosis, a challenge in its early detection.
CourseBy Darvin (Scott) Smith, MD, MSc
Long COVID/Long Lyme Expert Clinician Panel
1.5 CME. This panel aims to equip clinicians with the latest insights and evidence-based strategies for managing two challenging conditions: long COVID and long Lyme disease.
CourseBy John Lambert, MD
Long Lyme/Co-Infections and Long COVID | What do they have in common?
0.5 CME. This course provides a summary of similarities between clinical and biological manifestations of chronic Lyme disease and long COVID. It presents results of a published clinical trial on low dose naltrexone as an agent in long COVID.
CourseBy John Lambert, MD
Lyme carditis, more than blocked beats
1.0 CME. Lyme carditis is a serious and sometimes fatal manifestation of the infection.
CourseBy Elizabeth L. Maloney, MD
Managing Ixodes pacificus bites
1.0 CME. This presentation provides physicians with clinically useful information that will help them assist patients with known blacklegged tick bites.
CourseBy Elizabeth L. Maloney, MD
Managing Ixodes scapularis bites
1.0 CME. This presentation provides physicians with clinically useful information that will help them assist patients with known blacklegged tick bites.
CourseBy Elizabeth L. Maloney, MD
Measurement of high sensitivity troponin T in patients with early-stage Lyme disease: possible evidence for subclinical cardiac involvement
0.25 CME. This course gives an overview of a 2022 study that measured high-sensitivity troponin T in patients with early Lyme disease, and demonstrates that the causative bacteria of Lyme disease, Borrelia burgdorferi, may cause abnormal issues to the heart more often than previously thought, affecting 14.6% of these patients in the study.
CourseBy Elizabeth Lee-Lewandrowski, PhD
Neurologic complications of Lyme disease
0.5 CME. Many patients with Lyme disease develop neurological complications from the infection. This presentation focuses on small fiber neuropathy secondary to Lyme disease. It also discusses immune mechanisms implicated in the post-treatment Lyme disease syndrome (PTLDS) and reduced cerebral blood flow as a potential etiology for the cognitive complaints that are common in patients with PTLDS.
CourseBy Peter Novak, MD, PhD
Neurological manifestations of Bartonella species infections
1.0 CME. This module provides an overview of neurological manifestations reported in association with Bartonella spp. infections.
CourseBy Edward B. Breitschwerdt, DVM
Neuropsychiatric Symptoms with Lyme Disease & Tick-borne Illness
0.75 CME. This course is intended to help clinicians be aware of the mental health needs and risks in patients with Lyme disease and educates on appropriate professional mental health referral, based on symptoms and clinical presentation. This concise, data-driven overview will help clinicians quickly access the latest evidence on Lyme disease persistence after standard treatments, useful in overturning the long-held belief that Lyme disease is always easy to treat and cure.
CourseBy Shannon Delaney, MD, MA
One Health for Human Health Clinicians
1.0 CME. This course provides an overview of the One Health framework for human health clinicians and describes how this framework can be applied in human clinical practice.
CourseBy Cheryl Stroud, PhD, DVM
Part 1 | Bridging the Gap: A Panel Discussion on Human and Animal Health
1.0 CME. In the "Bridging the Gap: A Panel Discussion on Human and Animal Health" CME series, physicians will learn about the vital connection between human and animal health in managing chronic infectious diseases, featuring experts from diverse fields.
CourseBy Christine Green, MD
Part 2 | Bridging the Gap: A Panel Discussion on Human and Animal Health
1.0 CME. In the "Bridging the Gap: A Panel Discussion on Human and Animal Health" CME series, physicians will learn about the vital connection between human and animal health in managing chronic infectious diseases, featuring experts from diverse fields.
CourseBy Christine Green, MD
Part 3 | Bridging the Gap: A Panel Discussion on Human and Animal Health
1.0 CME. In the "Bridging the Gap: A Panel Discussion on Human and Animal Health" CME series, physicians will learn about the vital connection between human and animal health in managing chronic infectious diseases, featuring experts from diverse fields.
CourseBy Christine Green, MD
Pathogenic Bacteria Carried by Cat Fleas
0.5 CME. In Pathogenic Bacteria Carried by Cat Fleas, medical professionals are provided with comprehensive knowledge about the risks associated with infections transmitted by cat fleas.
CourseBy Erin Lashnits, DVM, PhD
Persistent Lyme disease
1.0 CME. This presentation provides physicians with clinically useful information that will help them assist patients with ongoing manifestations of Lyme disease following antibiotic therapy for Lyme disease.
CourseBy Elizabeth L. Maloney, MD
Racial Disparities in Lyme Disease
0.25 CME. This course uses two illustrative cases and CDC surveillance case data to discuss racial/ethnic health inequities and disparities in Lyme disease. It also discusses the role of improved clinician education in reducing known health disparities.
CourseBy Melissa Wright, MBA
Rocky Mountain Spotted Fever
CME Credit Pending. Dr. D. Scott Smith leads the new CME course "Rocky Mountain Spotted Fever" which provides comprehensive insights into diagnosing and treating this severe tick-borne disease.
CourseBy Darvin (Scott) Smith, MD, MSc
Serologic testing in Lyme disease
1.0 CME. This module discusses how clinicians may use serologic results in their diagnostic decision-making.
CourseBy Elizabeth L. Maloney, MD
Seven years of blood-based Lyme disease testing
0.5 CME. Many clinicians based diagnostic decisions on their assessment as to the likelihood that a patient has Lyme disease. Most consider epidemiologic data that is derived from surveillance case reports. However, this may underestimate risk for patients that reside in what has been considered traditionally low incidence states. This presentation documents the changing geographic demographics of the illness and clinicians in some areas of the country may need to reconsider how they assess a patient’s risk of Lyme disease.
CourseBy Elizabeth Lee-Lewandrowski, PhD
Seven years of blood-based testing for tick-borne infections other than Lyme disease
0.5 CME. This course provides a summary of a seven year experience of laboratory blood-based testing for tick-borne infections other than Lyme disease at a National Reference Laboratory and is intended to help guide clinical assessment of symptoms and diagnostic testing for tick-borne illnesses.
CourseBy Elizabeth Lee-Lewandrowski, PhD
The Intersection of PANDAS/PANS with Lyme Disease and Bartonellosis
CME pending. This course explores the multiple hits model of illness, the overlapping symptomatology of Borrelia and Bartonella infections, and the limitations of diagnostic testing for these conditions. It also hypothesizes how PANDAS/PANS symptoms might result from a wide variety of triggers, both infectious and non-infectious.
CourseBy Charlotte Mao, MD MPH
The impact of immune responses on diagnosis and treatment of Lyme disease
0.5 CME. This module covers a general overview of persistent infection in reservoir and incidental hosts, and immune evasion strategies utilized by the Lyme disease pathogen. Landmark studies on immune suppression by Borrelia are presented. An overview of diagnostic test modalities is discussed, along with recent findings on the variability of antibody responses in humans. Finally, the correlation of treatment success with immune responses is described.
CourseBy Monica Embers, PhD
When a blacklegged tick bite is more than a bite
0.25 CME. For blacklegged tick bites, you will learn general management principles and how to distinguish asymptomatic and symptomatic bites.
CourseBy Elizabeth L. Maloney, MD
Zoonotic diseases and pet cats
1.0 CME. This course will provide an introduction to the zoonotic diseases that can be carried and transmitted by pet cats, as well as an introduction to diseases that are important to consider with cat adoption and relocation. Finally an overview of disease prevention methods will be presented.
CourseBy Erin Lashnits, DVM, PhD
Zoonotic diseases and pet dogs
0.75 CME. This course will provide an introduction to the zoonotic diseases that can be carried and transmitted by pet dogs, as well as an introduction to diseases that may be imported during international dog adoption. The role of dogs as sentinels and clinical models for zoonotic diseases will be covered. Finally an overview of disease prevention methods will be presented.
CourseBy Erin Lashnits, DVM, PhD
43 products found